Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

33.25
+0.63001.93%
Post-market: 32.50-0.7500-2.26%19:48 EDT
Volume:284.01K
Turnover:9.36M
Market Cap:134.83M
PE:- -
High:33.75
Open:32.00
Low:31.66
Close:32.62
52wk High:42.39
52wk Low:13.60
Shares:4.05M
Float Shares:4.05M
Volume Ratio:1.10
T/O Rate:7.00%
Dividend:15.23
Dividend Rate:45.81%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Today’s Market Recap:U.S. Treasury Steps In to Stabilize Markets,Stocks Rally, Bitcoin Breaks $70,000, Moderna Surges 180%

TradingKey
·
Aug 20

ETF Daily | MRNX Soars 352%; MRNY Surges 169%; TEMC, TEMT Jump 48%; NUGT Climbs 18%; Gold Miners and Biotech Lead

ETF Tracker
·
Aug 20

Moderna Shares Surge 177% on Promising Cancer Vaccine Data, Crushing Short Sellers with $5.5 Billion in Losses

Stock News
·
Aug 20

24H | Crypto Stocks Jump Again; Chip, Optical Communications Stocks Rebound; Moderna Pull Back After a 177% Surge

US Overnight
·
Aug 20

Option Focus | Moderna's $525K Bear Call Spread and $1.67M Long-Dated Put Buy Reveal Institutions Bracing for a Major Downside Move

Option Witch
·
Aug 20

NASD Most Active Issues

Dow Jones
·
Aug 20

One Great Chart: Moderna Surge Makes S&P History

Dow Jones
·
Aug 20

Moderna price target raised to $89 from $39 at Morgan Stanley

TIPRANKS
·
Aug 20

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Dow Jones
·
Aug 20

Moderna's Cancer-Vaccine Breakthrough Drives Broad Biopharma Stock Rally

Dow Jones
·
Aug 20

US Stocks Close: Dow Rises Over 120 Points, SOX Drops 2%; Memory Stocks Lead Losses, SanDisk Falls 3.5%, Moderna Surges 177%

TradingKey
·
Aug 20

US Closing Bell | Unable to generate due to lack of news data

US Closing Bell
·
Aug 20

Moderna Shares More than Double on Success of mRNA Cancer Vaccine

Dow Jones
·
Aug 20

Moderna Raised to Outperform from Market Perform by William Blair

Dow Jones
·
Aug 20

Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Maintains Overweight Rating

MT Newswires Live
·
Aug 20

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

MT Newswires Live
·
Aug 20

Asia Morning Call-Global Markets

Reuters
·
Aug 20

Top Midday Gainers

MT Newswires Live
·
Aug 20

U.S. Stocks on the MOVE-ServiceNow, Zoom, US Homebuilders

Reuters
·
Aug 20

Moderna upgraded to Neutral from Underperform at BofA

TIPRANKS
·
Aug 20